Novacyt is a rapidly growing, international diagnostics group, generating revenues from the sale of diagnostic and pathogen testing kits based on molecular and protein testing technologies and sold into human clinical, life science, food and industrial markets.

Our Latest News

30 September 2021

R&D update

LEARN MORE

Novacyt 2021 AGM Registration and Voting Video

Our 2020 Annual Report

“We value your interest in Novacyt and taking the time to look at our web site. I am proud to be part of a dynamic, international business with an exciting portfolio of diagnostic platform products. At the heart of our business is the team of people with the skills and experience to execute our vision and objectives. I hope you will find our energetic, “can-do” culture rewarding irrespective of whether you are a customer, supplier, investor, employee or stake-holder of the business.”
Graham Mullis – CEO